Fig. 1 · Structure
Documents & Downloads
22-HDHA
Cytochrome P450
22-HDHA (22-Hydroxy Docosahexaenoic Acid) targets cytochrome P450 enzymes, particularly CYP4F3B, and serves as an oxidation product of docosahexaenoic acid (DHA). This bioactive compound is generated in vitro from the incubation of rat liver microsomes with DHA and NADPH. Human serum concentrations of 22-HDHA have been shown to increase following dietary supplementation with DHA, highlighting its potential relevance in studies of metabolic pathways and lipid metabolism.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 90780-46-4 |
| Applications | Cytochrome P450 |
| Formula | C22H32O3 |
| Molecular Weight | 344.49 |
| Synonyms | 22-Hydroxy Docosahexaenoic acid; 22-OH DHA |
| SMILES | OCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.